Forest Investigative Site 007 — New York, New York

Forest Investigative Site 007 is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Forest Investigative Site 007 has participated in 2 clinical trials.

Therapeutic areas: Generalized Anxiety Disorder, Type 2 Diabetes Mellitus.

Sponsors: Forest Laboratories, vTv Therapeutics.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 007?

Forest Investigative Site 007 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 007 conducted?

Forest Investigative Site 007 has 2 clinical trials on record. Their work covers Generalized Anxiety Disorder, Type 2 Diabetes Mellitus.

Is Forest Investigative Site 007 accredited by Crixeo Health?

Forest Investigative Site 007 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 007?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.